(Q42472074)

1 November 2017

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease (English)

1 reference

1 November 2017

0 references

1 reference

Boll MC

1

1 reference

1 November 2017

Sotelo J

2

1 reference

1 November 2017

Otero E

3

1 reference

1 November 2017

Alcaraz-Zubeldia M

4

1 reference

1 November 2017

Rios C

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

1 November 2017

1 reference

1 November 2017

265

1 reference

1 November 2017

3

1 reference

1 November 2017

155-158

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

1 November 2017

1 reference

7 January 2021

Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Deficiency of copper can cause neuronal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

New insights into the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Increased plasma lipid peroxidation in patients with aceruloplasminemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Raised cerebrospinal-fluid copper concentration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Depletion of copper and manganese in brain after MPTP treatment of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

Phospholipid peroxidation induced by the catechol-Fe3+(Cu2+) complex: a possible mechanism of nigrostriatal cell damage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

A new method for assay of ferroxidase activity and its application to human and rabbit sera

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900221-9

7 January 2021

10.1016/S0304-3940(99)00221-9

Identifiers

DOI

1 reference

1 November 2017

1 reference